The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration (FDA) and will be available within three months.
VIZZ works by gently shrinking the pupil of the eye, using aceclidine. This creates a “pinhole effect” – like narrowing a camera lens — which helps bring nearby objects into sharper focus. Unlike older eye drops, this one does not significantly affect the eye’s focusing muscles, so it doesn’t blur your distance vision or cause that “zoomed-in” effect (aka a myopic shift).
Ultimately, the drops offer improved reading vision for up to 10 hours, without the need for glasses and, importantly, without the side effects of older treatments.
For the lazys
Pretty cool, if it’s shown that it’s safe I can see myself using them
In a mirror then.